MDT240927C77000
- 12.70
- +0.66+5.48%
Medtronic Newsroom
TD Cowen Maintains Medtronic(MDT.US) With Buy Rating, Maintains Target Price $95
Medtronic's Buy Rating Justified by Growth in CST Sector and AiBLE's Market Integration
DBS Initiates Medtronic(MDT.US) With Hold Rating, Announces Target Price $90
Medtronic's Hold Rating: Financial Pressures and Market Shifts Impacting Profit Margins and Growth
BofA Securities Maintains Medtronic(MDT.US) With Buy Rating, Maintains Target Price $100
Medtronic Buy Rating Affirmed: Sustained Growth and Strong Pipeline Drive Positive Outlook
Wells Fargo Maintains Medtronic(MDT.US) With Buy Rating, Maintains Target Price $106
Wells Fargo Remains a Buy on Medtronic (MDT)
Analysts Have Conflicting Sentiments on These Healthcare Companies: Medtronic (MDT), Harmony Biosciences Holdings (HRMY) and Keros Therapeutics (KROS)
Barclays Maintains Medtronic(MDT.US) With Buy Rating, Maintains Target Price $105
Barclays Sticks to Their Buy Rating for Medtronic (MDT)
Truist Securities Maintains Hold on Medtronic, Raises Price Target to $90
Medtronic Analyst Ratings
Truist Financial Maintains Medtronic(MDT.US) With Hold Rating, Announces Target Price $90
Barclays Maintains Medtronic(MDT.US) With Buy Rating, Raises Target Price to $105
Barclays Maintains Overweight on Medtronic, Raises Price Target to $105
A Quick Look at Today's Ratings for Medtronic(MDT.US), With a Forecast Between $90 to $106
Medtronic Hold Rating Justified by Balanced Growth and Conservative Outlook
Argus Research Releases a Buy Rating on Medtronic (MDT)
A Quick Look at Today's Ratings for Medtronic(MDT.US), With a Forecast Between $87 to $106